APO Research
Talk to an analyst

APO RESEARCH · REPORT

Montelukast Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Montelukast Drug Industry Growth and Trends Forecast to 2032

20 December 2025124 pages

Choose your research edition.

Industry ResearchMontelukast Drug Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Montelukast Drug Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Montelukast Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Montelukast Drug Market Outlook and Growth Opportunities 2026212 pages · $4,250 USDMarket Analysis & ForecastGlobal Montelukast Drug Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global Montelukast Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Montelukast Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Montelukast Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Montelukast Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Montelukast Drug include Teva, Sandoz, Merck & Co., Mylan, Unimark, Unichem Laboratories, Torrent Pharmaceuticals, Shanghai Anbison Lab and Perrigo, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Montelukast Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Montelukast Drug market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Montelukast Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Montelukast Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Montelukast Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Montelukast Drug Market by Company

Teva

Sandoz

Merck & Co.

Mylan

Unimark

Unichem Laboratories

Torrent Pharmaceuticals

Shanghai Anbison Lab

Perrigo

MACLEODS

Lannett Company

Jubilant Pharma

Hikma Group

Hetero

Glenmark Pharmaceuticals

Dr. Reddys Laboratories

CSPC Ouyi Pharmaceutical

Cipla

Aurobindo Pharma

Apotex

Amneal Pharmaceuticals

Ajanta Pharma

Accord Healthcare

Montelukast Drug Segment by Type

Tablets

Oral Granules

Montelukast Drug Segment by Application

Hospital

Drug Store

Others

Montelukast Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Montelukast Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Montelukast Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Montelukast Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Montelukast Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Montelukast Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tablets Table 2. Major Company of Oral Granules Table 3. Global Montelukast Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Montelukast Drug Sales by Type (2021-2026) & (W Units) Table 5. Global Montelukast Drug Sales Market Share in Volume by Type (2021-2026) Table 6. Global Montelukast Drug Sales by Type (2021-2026) & (US$ Million) Table 7. Global Montelukast Drug Sales Market Share in Value by Type (2021-2026) Table 8. Global Montelukast Drug Price by Type (2021-2026) & (US$/Unit) Table 9. Global Montelukast Drug Sales by Type (2027-2032) & (W Units) Table 10. Global Montelukast Drug Sales Market Share in Volume by Type (2027-2032) Table 11. Global Montelukast Drug Sales by Type (2027-2032) & (US$ Million) Table 12. Global Montelukast Drug Sales Market Share in Value by Type (2027-2032) Table 13. Global Montelukast Drug Price by Type (2027-2032) & (US$/Unit) Table 14. North America Montelukast Drug Sales by Type (2021-2026) & (W Units) Table 15. North America Montelukast Drug Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Montelukast Drug Sales by Type (2021-2026) & (W Units) Table 17. Europe Montelukast Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Montelukast Drug Sales by Type (2021-2026) & (W Units) Table 19. Asia-Pacific Montelukast Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Montelukast Drug Sales by Type (2021-2026) & (W Units) Table 21. Latin America Montelukast Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Montelukast Drug Sales by Type (2021-2026) & (W Units) Table 23. Middle East and Africa Montelukast Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Montelukast Drug Industry Trends Table 25. Montelukast Drug Industry Drivers Table 26. Montelukast Drug Industry Opportunities and Challenges Table 27. Montelukast Drug Industry Restraints Table 28. Global Montelukast Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Montelukast Drug Revenue Market Share by Company (2021-2026) Table 30. Global Montelukast Drug Sales by Company (2021-2026) & (W Units) Table 31. Global Montelukast Drug Sales Share by Company (2021-2026) Table 32. Global Montelukast Drug Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Montelukast Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Montelukast Drug Major Company Production Sites and Headquarters Table 35. Global Montelukast Drug Company, Product Type & Application Table 36. Global Montelukast Drug Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Montelukast Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Montelukast Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Montelukast Drug Sales by Region (2021-2026) & (W Units) Table 41. Global Montelukast Drug Sales Market Share in Volume by Region (2021-2026) Table 42. Global Montelukast Drug Sales by Region (2021-2026) & (US$ Million) Table 43. Global Montelukast Drug Sales Market Share in Value by Region (2021-2026) Table 44. Global Montelukast Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Montelukast Drug Sales by Region (2027-2032) & (W Units) Table 46. Global Montelukast Drug Sales Market Share in Volume by Region (2027-2032) Table 47. Global Montelukast Drug Sales by Region (2027-2032) & (US$ Million) Table 48. Global Montelukast Drug Sales Market Share in Value by Region (2027-2032) Table 49. Global Montelukast Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Montelukast Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Montelukast Drug Sales by Application (2021-2026) & (W Units) Table 52. Global Montelukast Drug Sales Market Share in Volume by Application (2021-2026) Table 53. Global Montelukast Drug Sales by Application (2021-2026) & (US$ Million) Table 54. Global Montelukast Drug Sales Market Share in Value by Application (2021-2026) Table 55. Global Montelukast Drug Price by Application (2021-2026) & (US$/Unit) Table 56. Global Montelukast Drug Sales by Application (2027-2032) & (W Units) Table 57. Global Montelukast Drug Sales Market Share in Volume by Application (2027-2032) Table 58. Global Montelukast Drug Sales by Application (2027-2032) & (US$ Million) Table 59. Global Montelukast Drug Sales Market Share in Value by Application (2027-2032) Table 60. Global Montelukast Drug Price by Application (2027-2032) & (US$/Unit) Table 61. North America Montelukast Drug Sales by Application (2021-2026) & (W Units) Table 62. North America Montelukast Drug Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Montelukast Drug Sales by Application (2021-2026) & (W Units) Table 64. Europe Montelukast Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Montelukast Drug Sales by Application (2021-2026) & (W Units) Table 66. Asia-Pacific Montelukast Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Montelukast Drug Sales by Application (2021-2026) & (W Units) Table 68. Latin America Montelukast Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Montelukast Drug Sales by Application (2021-2026) & (W Units) Table 70. Middle East and Africa Montelukast Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Teva Company Information Table 72. Teva Business Overview Table 73. Teva Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Teva Montelukast Drug Product Portfolio Table 75. Teva Recent Development Table 76. Sandoz Company Information Table 77. Sandoz Business Overview Table 78. Sandoz Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Sandoz Montelukast Drug Product Portfolio Table 80. Sandoz Recent Development Table 81. Merck & Co. Company Information Table 82. Merck & Co. Business Overview Table 83. Merck & Co. Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Merck & Co. Montelukast Drug Product Portfolio Table 85. Merck & Co. Recent Development Table 86. Mylan Company Information Table 87. Mylan Business Overview Table 88. Mylan Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Mylan Montelukast Drug Product Portfolio Table 90. Mylan Recent Development Table 91. Unimark Company Information Table 92. Unimark Business Overview Table 93. Unimark Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Unimark Montelukast Drug Product Portfolio Table 95. Unimark Recent Development Table 96. Unichem Laboratories Company Information Table 97. Unichem Laboratories Business Overview Table 98. Unichem Laboratories Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Unichem Laboratories Montelukast Drug Product Portfolio Table 100. Unichem Laboratories Recent Development Table 101. Torrent Pharmaceuticals Company Information Table 102. Torrent Pharmaceuticals Business Overview Table 103. Torrent Pharmaceuticals Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Torrent Pharmaceuticals Montelukast Drug Product Portfolio Table 105. Torrent Pharmaceuticals Recent Development Table 106. Shanghai Anbison Lab Company Information Table 107. Shanghai Anbison Lab Business Overview Table 108. Shanghai Anbison Lab Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Shanghai Anbison Lab Montelukast Drug Product Portfolio Table 110. Shanghai Anbison Lab Recent Development Table 111. Perrigo Company Information Table 112. Perrigo Business Overview Table 113. Perrigo Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Perrigo Montelukast Drug Product Portfolio Table 115. Perrigo Recent Development Table 116. MACLEODS Company Information Table 117. MACLEODS Business Overview Table 118. MACLEODS Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. MACLEODS Montelukast Drug Product Portfolio Table 120. MACLEODS Recent Development Table 121. Lannett Company Company Information Table 122. Lannett Company Business Overview Table 123. Lannett Company Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Lannett Company Montelukast Drug Product Portfolio Table 125. Lannett Company Recent Development Table 126. Jubilant Pharma Company Information Table 127. Jubilant Pharma Business Overview Table 128. Jubilant Pharma Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Jubilant Pharma Montelukast Drug Product Portfolio Table 130. Jubilant Pharma Recent Development Table 131. Hikma Group Company Information Table 132. Hikma Group Business Overview Table 133. Hikma Group Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Hikma Group Montelukast Drug Product Portfolio Table 135. Hikma Group Recent Development Table 136. Hetero Company Information Table 137. Hetero Business Overview Table 138. Hetero Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Hetero Montelukast Drug Product Portfolio Table 140. Hetero Recent Development Table 141. Glenmark Pharmaceuticals Company Information Table 142. Glenmark Pharmaceuticals Business Overview Table 143. Glenmark Pharmaceuticals Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Glenmark Pharmaceuticals Montelukast Drug Product Portfolio Table 145. Glenmark Pharmaceuticals Recent Development Table 146. Dr. Reddys Laboratories Company Information Table 147. Dr. Reddys Laboratories Business Overview Table 148. Dr. Reddys Laboratories Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Dr. Reddys Laboratories Montelukast Drug Product Portfolio Table 150. Dr. Reddys Laboratories Recent Development Table 151. CSPC Ouyi Pharmaceutical Company Information Table 152. CSPC Ouyi Pharmaceutical Business Overview Table 153. CSPC Ouyi Pharmaceutical Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. CSPC Ouyi Pharmaceutical Montelukast Drug Product Portfolio Table 155. CSPC Ouyi Pharmaceutical Recent Development Table 156. Cipla Company Information Table 157. Cipla Business Overview Table 158. Cipla Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. Cipla Montelukast Drug Product Portfolio Table 160. Cipla Recent Development Table 161. Aurobindo Pharma Company Information Table 162. Aurobindo Pharma Business Overview Table 163. Aurobindo Pharma Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 164. Aurobindo Pharma Montelukast Drug Product Portfolio Table 165. Aurobindo Pharma Recent Development Table 166. Apotex Company Information Table 167. Apotex Business Overview Table 168. Apotex Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 169. Apotex Montelukast Drug Product Portfolio Table 170. Apotex Recent Development Table 171. Amneal Pharmaceuticals Company Information Table 172. Amneal Pharmaceuticals Business Overview Table 173. Amneal Pharmaceuticals Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 174. Amneal Pharmaceuticals Montelukast Drug Product Portfolio Table 175. Amneal Pharmaceuticals Recent Development Table 176. Ajanta Pharma Company Information Table 177. Ajanta Pharma Business Overview Table 178. Ajanta Pharma Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 179. Ajanta Pharma Montelukast Drug Product Portfolio Table 180. Ajanta Pharma Recent Development Table 181. Accord Healthcare Company Information Table 182. Accord Healthcare Business Overview Table 183. Accord Healthcare Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 184. Accord Healthcare Montelukast Drug Product Portfolio Table 185. Accord Healthcare Recent Development Table 186. North America Montelukast Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 187. North America Montelukast Drug Sales by Country (2021-2026) & (W Units) Table 188. North America Montelukast Drug Sales Market Share by Country (2021-2026) Table 189. North America Montelukast Drug Sales Forecast by Country (2027-2032) & (W Units) Table 190. North America Montelukast Drug Sales Market Share Forecast by Country (2027-2032) Table 191. North America Montelukast Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. North America Montelukast Drug Market Size by Country (2021-2026) & (US$ Million) Table 193. North America Montelukast Drug Market Share by Country (2021-2026) Table 194. North America Montelukast Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. North America Montelukast Drug Market Share Forecast by Country (2027-2032) Table 196. Europe Montelukast Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 197. Europe Montelukast Drug Sales by Country (2021-2026) & (W Units) Table 198. Europe Montelukast Drug Sales Market Share by Country (2021-2026) Table 199. Europe Montelukast Drug Sales Forecast by Country (2027-2032) & (W Units) Table 200. Europe Montelukast Drug Sales Market Share Forecast by Country (2027-2032) Table 201. Europe Montelukast Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. Europe Montelukast Drug Market Size by Country (2021-2026) & (US$ Million) Table 203. Europe Montelukast Drug Market Share by Country (2021-2026) Table 204. Europe Montelukast Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. Europe Montelukast Drug Market Share Forecast by Country (2027-2032) Table 206. Asia-Pacific Montelukast Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 207. Asia-Pacific Montelukast Drug Sales by Country (2021-2026) & (W Units) Table 208. Asia-Pacific Montelukast Drug Sales Market Share by Country (2021-2026) Table 209. Asia-Pacific Montelukast Drug Sales Forecast by Country (2027-2032) & (W Units) Table 210. Asia-Pacific Montelukast Drug Sales Market Share Forecast by Country (2027-2032) Table 211. Asia-Pacific Montelukast Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 212. Asia-Pacific Montelukast Drug Market Size by Country (2021-2026) & (US$ Million) Table 213. Asia-Pacific Montelukast Drug Market Share by Country (2021-2026) Table 214. Asia-Pacific Montelukast Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 215. Asia-Pacific Montelukast Drug Market Share Forecast by Country (2027-2032) Table 216. Latin America Montelukast Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 217. Latin America Montelukast Drug Sales by Country (2021-2026) & (W Units) Table 218. Latin America Montelukast Drug Sales Market Share by Country (2021-2026) Table 219. Latin America Montelukast Drug Sales Forecast by Country (2027-2032) & (W Units) Table 220. Latin America Montelukast Drug Sales Market Share Forecast by Country (2027-2032) Table 221. Latin America Montelukast Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 222. Latin America Montelukast Drug Market Size by Country (2021-2026) & (US$ Million) Table 223. Latin America Montelukast Drug Market Share by Country (2021-2026) Table 224. Latin America Montelukast Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 225. Latin America Montelukast Drug Market Share Forecast by Country (2027-2032) Table 226. Middle East and Africa Montelukast Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 227. Middle East and Africa Montelukast Drug Sales by Country (2021-2026) & (W Units) Table 228. Middle East and Africa Montelukast Drug Sales Market Share by Country (2021-2026) Table 229. Middle East and Africa Montelukast Drug Sales Forecast by Country (2027-2032) & (W Units) Table 230. Middle East and Africa Montelukast Drug Sales Market Share Forecast by Country (2027-2032) Table 231. Middle East and Africa Montelukast Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 232. Middle East and Africa Montelukast Drug Market Size by Country (2021-2026) & (US$ Million) Table 233. Middle East and Africa Montelukast Drug Market Share by Country (2021-2026) Table 234. Middle East and Africa Montelukast Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 235. Middle East and Africa Montelukast Drug Market Share Forecast by Country (2027-2032) Table 236. Key Raw Materials Table 237. Raw Materials Key Suppliers Table 238. Montelukast Drug Distributors List Table 239. Montelukast Drug Customers List Table 240. Research Programs/Design for This Report Table 241. Authors List of This Report Table 242. Secondary Sources Table 243. Primary Sources List of Figures Figure 1. Montelukast Drug Image Figure 2. Global Montelukast Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Montelukast Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Montelukast Drug Sales (2021-2032) & (W Units) Figure 5. Tablets Image Figure 6. Global Tablets Sales YoY Growth (2021-2032) & (W Units) Figure 7. Oral Granules Image Figure 8. Global Oral Granules Sales YoY Growth (2021-2032) & (W Units) Figure 9. Global Montelukast Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Montelukast Drug Market Share by Type 2025 VS 2032 Figure 11. North America Montelukast Drug Sales Market Share in Volume by Type in 2025 Figure 12. North America Montelukast Drug Sales Market Share in Value by Type in 2025 Figure 13. Europe Montelukast Drug Sales Market Share in Volume by Type in 2025 Figure 14. Europe Montelukast Drug Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Montelukast Drug Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Montelukast Drug Sales Market Share in Value by Type in 2025 Figure 17. Latin America Montelukast Drug Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Montelukast Drug Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Montelukast Drug Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Montelukast Drug Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Montelukast Drug Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (W Units) Figure 25. Drug Store Image Figure 26. Global Drug Store Sales YoY Growth (2021-2032) & (W Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 29. Global Montelukast Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Montelukast Drug Market Share by Application 2025 VS 2032 Figure 31. North America Montelukast Drug Sales Market Share in Volume by Application in 2025 Figure 32. North America Montelukast Drug Sales Market Share in Value by Application in 2025 Figure 33. Europe Montelukast Drug Sales Market Share in Volume by Application in 2025 Figure 34. Europe Montelukast Drug Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Montelukast Drug Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Montelukast Drug Sales Market Share in Value by Application in 2025 Figure 37. Latin America Montelukast Drug Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Montelukast Drug Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Montelukast Drug Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Montelukast Drug Sales Market Share in Value by Application in 2025 Figure 41. North America Montelukast Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 42. North America Montelukast Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Montelukast Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Montelukast Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Montelukast Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 46. Europe Montelukast Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Montelukast Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Montelukast Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Montelukast Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 50. Asia-Pacific Montelukast Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Montelukast Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Montelukast Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Montelukast Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. Latin America Montelukast Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Montelukast Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Montelukast Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Montelukast Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Middle East and Africa Montelukast Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Montelukast Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Montelukast Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Montelukast Drug Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Montelukast Drug Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Oral Granules
Applications
  • Hospital
  • Drug Store
  • Others
Companies covered
  • Teva
  • Sandoz
  • Merck & Co.
  • Mylan
  • Unimark
  • Unichem Laboratories
  • Torrent Pharmaceuticals
  • Shanghai Anbison Lab
  • Perrigo
  • MACLEODS
  • Lannett Company
  • Jubilant Pharma
  • Hikma Group
  • Hetero
  • Glenmark Pharmaceuticals
  • Dr. Reddys Laboratories
  • CSPC Ouyi Pharmaceutical
  • Cipla
  • Aurobindo Pharma
  • Apotex
  • Amneal Pharmaceuticals
  • Ajanta Pharma
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Montelukast Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Montelukast Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Montelukast Drug Market by Type
  6. 1.3.1 Tablets
  7. 1.3.2 Oral Granules
  8. 1.4 Global Montelukast Drug Market Size by Type
  9. 1.4.1 Global Montelukast Drug Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Montelukast Drug Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Montelukast Drug Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Montelukast Drug Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Montelukast Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Montelukast Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Montelukast Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Montelukast Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Montelukast Drug Industry Trends
  2. 2.2 Montelukast Drug Industry Drivers
  3. 2.3 Montelukast Drug Industry Opportunities and Challenges
  4. 2.4 Montelukast Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Montelukast Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Montelukast Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Montelukast Drug Price (2021-2026)
  4. 3.4 Global Montelukast Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Montelukast Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Montelukast Drug Company, Product Type & Application
  7. 3.7 Global Montelukast Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Montelukast Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Montelukast Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Montelukast Drug Tier 1, Tier 2, and Tier 3
4 Montelukast Drug Regional Status and Outlook
  1. 4.1 Global Montelukast Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Montelukast Drug Historic Market Size by Region
  3. 4.2.1 Global Montelukast Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Montelukast Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Montelukast Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Montelukast Drug Forecasted Market Size by Region
  7. 4.3.1 Global Montelukast Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Montelukast Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Montelukast Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Montelukast Drug by Application
  1. 5.1 Montelukast Drug Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Drug Store
  4. 5.1.3 Others
  5. 5.2 Global Montelukast Drug Market Size by Application
  6. 5.2.1 Global Montelukast Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Montelukast Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Montelukast Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Montelukast Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Montelukast Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Montelukast Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Montelukast Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Montelukast Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Montelukast Drug Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Sandoz
  8. 6.2.1 Sandoz Company Information
  9. 6.2.2 Sandoz Business Overview
  10. 6.2.3 Sandoz Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sandoz Montelukast Drug Product Portfolio
  12. 6.2.5 Sandoz Recent Developments
  13. 6.3 Merck & Co.
  14. 6.3.1 Merck & Co. Company Information
  15. 6.3.2 Merck & Co. Business Overview
  16. 6.3.3 Merck & Co. Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck & Co. Montelukast Drug Product Portfolio
  18. 6.3.5 Merck & Co. Recent Developments
  19. 6.4 Mylan
  20. 6.4.1 Mylan Company Information
  21. 6.4.2 Mylan Business Overview
  22. 6.4.3 Mylan Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Mylan Montelukast Drug Product Portfolio
  24. 6.4.5 Mylan Recent Developments
  25. 6.5 Unimark
  26. 6.5.1 Unimark Company Information
  27. 6.5.2 Unimark Business Overview
  28. 6.5.3 Unimark Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Unimark Montelukast Drug Product Portfolio
  30. 6.5.5 Unimark Recent Developments
  31. 6.6 Unichem Laboratories
  32. 6.6.1 Unichem Laboratories Company Information
  33. 6.6.2 Unichem Laboratories Business Overview
  34. 6.6.3 Unichem Laboratories Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Unichem Laboratories Montelukast Drug Product Portfolio
  36. 6.6.5 Unichem Laboratories Recent Developments
  37. 6.7 Torrent Pharmaceuticals
  38. 6.7.1 Torrent Pharmaceuticals Company Information
  39. 6.7.2 Torrent Pharmaceuticals Business Overview
  40. 6.7.3 Torrent Pharmaceuticals Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Torrent Pharmaceuticals Montelukast Drug Product Portfolio
  42. 6.7.5 Torrent Pharmaceuticals Recent Developments
  43. 6.8 Shanghai Anbison Lab
  44. 6.8.1 Shanghai Anbison Lab Company Information
  45. 6.8.2 Shanghai Anbison Lab Business Overview
  46. 6.8.3 Shanghai Anbison Lab Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Shanghai Anbison Lab Montelukast Drug Product Portfolio
  48. 6.8.5 Shanghai Anbison Lab Recent Developments
  49. 6.9 Perrigo
  50. 6.9.1 Perrigo Company Information
  51. 6.9.2 Perrigo Business Overview
  52. 6.9.3 Perrigo Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Perrigo Montelukast Drug Product Portfolio
  54. 6.9.5 Perrigo Recent Developments
  55. 6.10 MACLEODS
  56. 6.10.1 MACLEODS Company Information
  57. 6.10.2 MACLEODS Business Overview
  58. 6.10.3 MACLEODS Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 MACLEODS Montelukast Drug Product Portfolio
  60. 6.10.5 MACLEODS Recent Developments
  61. 6.11 Lannett Company
  62. 6.11.1 Lannett Company Company Information
  63. 6.11.2 Lannett Company Business Overview
  64. 6.11.3 Lannett Company Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Lannett Company Montelukast Drug Product Portfolio
  66. 6.11.5 Lannett Company Recent Developments
  67. 6.12 Jubilant Pharma
  68. 6.12.1 Jubilant Pharma Company Information
  69. 6.12.2 Jubilant Pharma Business Overview
  70. 6.12.3 Jubilant Pharma Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Jubilant Pharma Montelukast Drug Product Portfolio
  72. 6.12.5 Jubilant Pharma Recent Developments
  73. 6.13 Hikma Group
  74. 6.13.1 Hikma Group Company Information
  75. 6.13.2 Hikma Group Business Overview
  76. 6.13.3 Hikma Group Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Hikma Group Montelukast Drug Product Portfolio
  78. 6.13.5 Hikma Group Recent Developments
  79. 6.14 Hetero
  80. 6.14.1 Hetero Company Information
  81. 6.14.2 Hetero Business Overview
  82. 6.14.3 Hetero Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Hetero Montelukast Drug Product Portfolio
  84. 6.14.5 Hetero Recent Developments
  85. 6.15 Glenmark Pharmaceuticals
  86. 6.15.1 Glenmark Pharmaceuticals Company Information
  87. 6.15.2 Glenmark Pharmaceuticals Business Overview
  88. 6.15.3 Glenmark Pharmaceuticals Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Glenmark Pharmaceuticals Montelukast Drug Product Portfolio
  90. 6.15.5 Glenmark Pharmaceuticals Recent Developments
  91. 6.16 Dr. Reddys Laboratories
  92. 6.16.1 Dr. Reddys Laboratories Company Information
  93. 6.16.2 Dr. Reddys Laboratories Business Overview
  94. 6.16.3 Dr. Reddys Laboratories Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Dr. Reddys Laboratories Montelukast Drug Product Portfolio
  96. 6.16.5 Dr. Reddys Laboratories Recent Developments
  97. 6.17 CSPC Ouyi Pharmaceutical
  98. 6.17.1 CSPC Ouyi Pharmaceutical Company Information
  99. 6.17.2 CSPC Ouyi Pharmaceutical Business Overview
  100. 6.17.3 CSPC Ouyi Pharmaceutical Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 CSPC Ouyi Pharmaceutical Montelukast Drug Product Portfolio
  102. 6.17.5 CSPC Ouyi Pharmaceutical Recent Developments
  103. 6.18 Cipla
  104. 6.18.1 Cipla Company Information
  105. 6.18.2 Cipla Business Overview
  106. 6.18.3 Cipla Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Cipla Montelukast Drug Product Portfolio
  108. 6.18.5 Cipla Recent Developments
  109. 6.19 Aurobindo Pharma
  110. 6.19.1 Aurobindo Pharma Company Information
  111. 6.19.2 Aurobindo Pharma Business Overview
  112. 6.19.3 Aurobindo Pharma Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Aurobindo Pharma Montelukast Drug Product Portfolio
  114. 6.19.5 Aurobindo Pharma Recent Developments
  115. 6.20 Apotex
  116. 6.20.1 Apotex Company Information
  117. 6.20.2 Apotex Business Overview
  118. 6.20.3 Apotex Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Apotex Montelukast Drug Product Portfolio
  120. 6.20.5 Apotex Recent Developments
  121. 6.21 Amneal Pharmaceuticals
  122. 6.21.1 Amneal Pharmaceuticals Company Information
  123. 6.21.2 Amneal Pharmaceuticals Business Overview
  124. 6.21.3 Amneal Pharmaceuticals Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Amneal Pharmaceuticals Montelukast Drug Product Portfolio
  126. 6.21.5 Amneal Pharmaceuticals Recent Developments
  127. 6.22 Ajanta Pharma
  128. 6.22.1 Ajanta Pharma Company Information
  129. 6.22.2 Ajanta Pharma Business Overview
  130. 6.22.3 Ajanta Pharma Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Ajanta Pharma Montelukast Drug Product Portfolio
  132. 6.22.5 Ajanta Pharma Recent Developments
  133. 6.23 Accord Healthcare
  134. 6.23.1 Accord Healthcare Company Information
  135. 6.23.2 Accord Healthcare Business Overview
  136. 6.23.3 Accord Healthcare Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 Accord Healthcare Montelukast Drug Product Portfolio
  138. 6.23.5 Accord Healthcare Recent Developments
7 North America by Country
  1. 7.1 North America Montelukast Drug Sales by Country
  2. 7.1.1 North America Montelukast Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Montelukast Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Montelukast Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Montelukast Drug Market Size by Country
  6. 7.2.1 North America Montelukast Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Montelukast Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Montelukast Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Montelukast Drug Sales by Country
  2. 8.1.1 Europe Montelukast Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Montelukast Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Montelukast Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Montelukast Drug Market Size by Country
  6. 8.2.1 Europe Montelukast Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Montelukast Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Montelukast Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Montelukast Drug Sales by Country
  2. 9.1.1 Asia-Pacific Montelukast Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Montelukast Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Montelukast Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Montelukast Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Montelukast Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Montelukast Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Montelukast Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Montelukast Drug Sales by Country
  2. 10.1.1 South America Montelukast Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Montelukast Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Montelukast Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Montelukast Drug Market Size by Country
  6. 10.2.1 South America Montelukast Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Montelukast Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Montelukast Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Montelukast Drug Sales by Country
  2. 11.1.1 Middle East and Africa Montelukast Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Montelukast Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Montelukast Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Montelukast Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Montelukast Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Montelukast Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Montelukast Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Montelukast Drug Value Chain Analysis
  2. 12.1.1 Montelukast Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Montelukast Drug Production Mode & Process
  7. 12.2 Montelukast Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Montelukast Drug Distributors
  10. 12.2.3 Montelukast Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst